Further, Asxl2 loss cooperates with RUNX1-RUNX1T1 to promote leukemogenesis in mice [204], which supports the clinical occurrence of ASXL2 mutations in RUNX1-RUNX1T1 AML patients. The gene discussed is ASXL2; the disease is acute myeloid leukemia.